117 related articles for article (PubMed ID: 2230996)
1. The potential of 2-deoxy-2[18F]fluoro-D-glucose (FDG) for the detection of tumor involvement in lymph nodes.
Wahl RL; Kaminski MS; Ethier SP; Hutchins GD
J Nucl Med; 1990 Nov; 31(11):1831-5. PubMed ID: 2230996
[TBL] [Abstract][Full Text] [Related]
2. Prospective evaluation of fluorine-18 fluorodeoxyclucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistry.
Utech CI; Young CS; Winter PF
Eur J Nucl Med; 1996 Dec; 23(12):1588-93. PubMed ID: 8929312
[TBL] [Abstract][Full Text] [Related]
3. Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI.
Braams JW; Pruim J; Freling NJ; Nikkels PG; Roodenburg JL; Boering G; Vaalburg W; Vermey A
J Nucl Med; 1995 Feb; 36(2):211-6. PubMed ID: 7830116
[TBL] [Abstract][Full Text] [Related]
4. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
Schaefferkoetter JD; Carlson ER; Heidel RE
J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer.
Nieweg OE; Kim EE; Wong WH; Broussard WF; Singletary SE; Hortobagyi GN; Tilbury RS
Cancer; 1993 Jun; 71(12):3920-5. PubMed ID: 8389655
[TBL] [Abstract][Full Text] [Related]
6. Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma.
Gritters LS; Francis IR; Zasadny KR; Wahl RL
J Nucl Med; 1993 Sep; 34(9):1420-7. PubMed ID: 8355058
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET.
Adler LP; Crowe JP; al-Kaisi NK; Sunshine JL
Radiology; 1993 Jun; 187(3):743-50. PubMed ID: 8497624
[TBL] [Abstract][Full Text] [Related]
8. Uptake of 2-deoxy, 2-(18F) fluoro-D-glucose in bladder cancer: animal localization and initial patient positron emission tomography.
Harney JV; Wahl RL; Liebert M; Kuhl DE; Hutchins GD; Wedemeyer G; Grossman HB
J Urol; 1991 Feb; 145(2):279-83. PubMed ID: 1988718
[TBL] [Abstract][Full Text] [Related]
9. Initial assessment of positron emission tomography for detection of nonpalpable regional lymphatic metastases in melanoma.
Wagner JD; Schauwecker D; Hutchins G; Coleman JJ
J Surg Oncol; 1997 Mar; 64(3):181-9. PubMed ID: 9121147
[TBL] [Abstract][Full Text] [Related]
10. 18F-2-deoxy-2-fluoro-D-glucose uptake into human tumor xenografts. Feasibility studies for cancer imaging with positron-emission tomography.
Wahl RL; Hutchins GD; Buchsbaum DJ; Liebert M; Grossman HB; Fisher S
Cancer; 1991 Mar; 67(6):1544-50. PubMed ID: 2001543
[TBL] [Abstract][Full Text] [Related]
11. Influence of chemotherapy on FDG uptake by human cancer xenografts in nude mice.
Yoshioka T; Takahashi H; Oikawa H; Maeda S; Ido T; Akaizawa T; Fukuda H; Kanamaru R
J Nucl Med; 1997 May; 38(5):714-7. PubMed ID: 9170434
[TBL] [Abstract][Full Text] [Related]
12. Implication of ¹⁸F-Fluorodeoxyglucose Uptake of Affected Axillary Lymph Nodes in Cases with Breast Cancer.
Fujii T; Yajima R; Tatsuki H; Oosone K; Kuwano H
Anticancer Res; 2016 Jan; 36(1):393-7. PubMed ID: 26722071
[TBL] [Abstract][Full Text] [Related]
13. Early changes in fluorine-18-FDG uptake during radiotherapy.
Hautzel H; Müller-Gärtner HW
J Nucl Med; 1997 Sep; 38(9):1384-6. PubMed ID: 9293793
[TBL] [Abstract][Full Text] [Related]
14. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis.
Lewis PJ; Salama A
J Nucl Med; 1994 Oct; 35(10):1647-9. PubMed ID: 7931664
[TBL] [Abstract][Full Text] [Related]
15. Comparative PET imaging of experimental tumors with bromine-76-labeled antibodies, fluorine-18-fluorodeoxyglucose and carbon-11-methionine.
Lövqvist A; Sundin A; Roberto A; Ahlström H; Carlsson J; Lundqvist H
J Nucl Med; 1997 Jul; 38(7):1029-35. PubMed ID: 9225786
[TBL] [Abstract][Full Text] [Related]
16. [Positron emission tomography for primary tumor detection in lymph node metastases with unknown primary tumor].
Schipper JH; Schrader M; Arweiler D; Müller S; Sciuk J
HNO; 1996 May; 44(5):254-7. PubMed ID: 8707630
[TBL] [Abstract][Full Text] [Related]
17. Tumor diagnosis by PET: potential of seven tracers examined in five experimental tumors including an artificial metastasis model.
Ishiwata K; Takahashi T; Iwata R; Tomura M; Tada M; Itoh J; Kameyama M; Ido T
Int J Rad Appl Instrum B; 1992 Aug; 19(6):611-8. PubMed ID: 1387872
[TBL] [Abstract][Full Text] [Related]
18. Lymphoscintigraphy of human colorectal carcinoma metastases in athymic mice by use of radioiodinated B72.3 monoclonal antibody.
Shah SA; Gallagher BM; Sands H
J Natl Cancer Inst; 1987 Jun; 78(6):1069-77. PubMed ID: 3473248
[TBL] [Abstract][Full Text] [Related]
19. Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study.
Yoon YC; Lee KS; Shim YM; Kim BT; Kim K; Kim TS
Radiology; 2003 Jun; 227(3):764-70. PubMed ID: 12773680
[TBL] [Abstract][Full Text] [Related]
20. Experimental study for cancer diagnosis with positron-labeled fluorinated glucose analogs: [18F]-2-fluoro-2-deoxy-D-mannose: a new tracer for cancer detection.
Fukuda H; Matsuzawa T; Abe Y; Endo S; Yamada K; Kubota K; Hatazawa J; Sato T; Ito M; Takahashi T; Iwata R; Ido T
Eur J Nucl Med; 1982; 7(7):294-7. PubMed ID: 6981508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
